Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives
Ocular fibrosis leads to severe visual impairment and blindness worldwide, being a major area of unmet need in ophthalmology and medicine. To date, the only available treatments are antimetabolite drugs that have significant potentially blinding side effects, such as tissue damage and infection. The...
Saved in:
Main Authors: | Fabiana Mallone, Roberta Costi, Marco Marenco, Rocco Plateroti, Antonio Minni, Giuseppe Attanasio, Marco Artico, Alessandro Lambiase |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cb71e9d22f7f40b3b57e8b81fe01434e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis
by: Iyer JV, et al.
Published: (2017) -
Trends in the characteristics of vitrectomy in Eastern China
by: Fang Y, et al.
Published: (2018) -
Current Situation and Prospect of Teleophthalmology
by: ZHANG Xiao, et al.
Published: (2021) -
Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance
by: Davey PG, et al.
Published: (2016) -
Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution
by: Lee D, et al.
Published: (2017)